Structural Features Underlying Selective Inhibition of GSK3β by Dibromocantharelline: Implications for Rational Drug Design
Version of Record online: 19 JAN 2011
© 2011 John Wiley & Sons A/S
Chemical Biology & Drug Design
Volume 77, Issue 3, pages 199–205, March 2011
How to Cite
Zhang, N., Zhong, R., Yan, H. and Jiang, Y. (2011), Structural Features Underlying Selective Inhibition of GSK3β by Dibromocantharelline: Implications for Rational Drug Design. Chemical Biology & Drug Design, 77: 199–205. doi: 10.1111/j.1747-0285.2010.01069.x
- Issue online: 9 FEB 2011
- Version of Record online: 19 JAN 2011
- Accepted manuscript online: 22 DEC 2010 11:46AM EST
- Received 5 April 2010, revised 12 October 2010 and accepted for publication 11 December 2010
Figure S1. Time evolution of heavy atoms RMSD for GSK3β (upper) and DT (lower) from the initial minimized structure.
|CBDD_1069_sm_FigureLegend.doc||24K||Supporting info item|
|CBDD_1069_sm_Figure.tif||496K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.